tirzepatide osa approval This study by Malhotra et al., published in the NEJM investigated the effects of (Zepbound), a GIP and GLP-1 agonist, on obstructive sleep apnea (OSA) and related outcomes in adults with Zepbound (tirzepatide) is the first

Myo-inositol oxygenase overexpression accentuates generation of reactive oxygen species and exacerbates cellular injury following high glucose ambience: A new mechanism relevant to the pathogenesis of diabetic nephropathy

Sleep optimization (7-9 hours nightly) and stress reduction also contribute to weight maintenance by regulating hormones that influence appetite and metabolism

It greatly benefits those with weight-related health issues such as type 2 diabetes, hypertension, or high cholesterol

None of the other authors has any financial or personal relationships that could inappropriately influence or bias the content of the paper

Diarrhoea may also occur, particularly in the early weeks

Supplements are also playing an increasingly recognized role